CN106072560A - 一种用于治疗痛风的保健品及其制备方法 - Google Patents
一种用于治疗痛风的保健品及其制备方法 Download PDFInfo
- Publication number
- CN106072560A CN106072560A CN201610498560.3A CN201610498560A CN106072560A CN 106072560 A CN106072560 A CN 106072560A CN 201610498560 A CN201610498560 A CN 201610498560A CN 106072560 A CN106072560 A CN 106072560A
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- gout
- raw material
- health product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000005569 Gout Diseases 0.000 title claims abstract description 68
- 230000036541 health Effects 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 239000000284 extract Substances 0.000 claims abstract description 58
- 239000002994 raw material Substances 0.000 claims abstract description 54
- 239000011812 mixed powder Substances 0.000 claims abstract description 33
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 23
- 239000011669 selenium Substances 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 241000222336 Ganoderma Species 0.000 claims abstract description 19
- 239000000843 powder Substances 0.000 claims abstract description 19
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 17
- 235000014435 Mentha Nutrition 0.000 claims abstract description 15
- 241001072983 Mentha Species 0.000 claims abstract description 15
- 108090000526 Papain Proteins 0.000 claims abstract description 15
- 239000004365 Protease Substances 0.000 claims abstract description 15
- 235000019834 papain Nutrition 0.000 claims abstract description 15
- 229940055729 papain Drugs 0.000 claims abstract description 15
- 229920001202 Inulin Polymers 0.000 claims abstract description 14
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 14
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 14
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 14
- 229940029339 inulin Drugs 0.000 claims abstract description 14
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 13
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 11
- 239000012141 concentrate Substances 0.000 claims abstract description 4
- 238000007654 immersion Methods 0.000 claims description 11
- 239000002674 ointment Substances 0.000 claims description 10
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 235000002710 Ilex cornuta Nutrition 0.000 claims description 2
- 241001310146 Ilex cornuta Species 0.000 claims description 2
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 33
- 239000000463 material Substances 0.000 abstract description 11
- 208000001132 Osteoporosis Diseases 0.000 abstract description 2
- 230000032683 aging Effects 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 230000004060 metabolic process Effects 0.000 abstract description 2
- 239000003814 drug Substances 0.000 description 29
- 208000002193 Pain Diseases 0.000 description 21
- 229940091258 selenium supplement Drugs 0.000 description 19
- 229940079593 drug Drugs 0.000 description 13
- 239000004615 ingredient Substances 0.000 description 11
- 230000008961 swelling Effects 0.000 description 9
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 6
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 238000004090 dissolution Methods 0.000 description 5
- 238000002791 soaking Methods 0.000 description 5
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 4
- 241000283707 Capra Species 0.000 description 4
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 229940116269 uric acid Drugs 0.000 description 4
- 235000007516 Chrysanthemum Nutrition 0.000 description 3
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 240000000249 Morus alba Species 0.000 description 3
- 235000008708 Morus alba Nutrition 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 210000002683 foot Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010023232 Joint swelling Diseases 0.000 description 2
- 244000062793 Sorghum vulgare Species 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229960001338 colchicine Drugs 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 235000001916 dieting Nutrition 0.000 description 2
- 230000037228 dieting effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 235000021271 drinking Nutrition 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 150000002630 limonoids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000008518 lycium barbarum polysaccharide Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000019713 millet Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 235000014102 seafood Nutrition 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 108010043137 Actomyosin Proteins 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 244000182067 Fraxinus ornus Species 0.000 description 1
- 235000002917 Fraxinus ornus Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical group C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- VHLJDTBGULNCGF-UHFFFAOYSA-N Limonin Natural products CC1(C)OC2CC(=O)OCC23C4CCC5(C)C(CC(=O)C6OC56C4(C)C(=O)CC13)c7cocc7 VHLJDTBGULNCGF-UHFFFAOYSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033664 Panic attack Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000972673 Phellodendron amurense Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241000133134 Saussurea Species 0.000 description 1
- 241001145025 Saussurea involucrata Species 0.000 description 1
- 229920000377 Sinistrin Polymers 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
- 229960003459 allopurinol Drugs 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 229940106705 chlorophyll Drugs 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 230000011382 collagen catabolic process Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000021433 fructose syrup Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 208000019906 panic disease Diseases 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- WJNRPILHGGKWCK-UHFFFAOYSA-N propazine Chemical compound CC(C)NC1=NC(Cl)=NC(NC(C)C)=N1 WJNRPILHGGKWCK-UHFFFAOYSA-N 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 230000004144 purine metabolism Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 210000001171 synovial bursa Anatomy 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 210000001226 toe joint Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于治疗痛风的保健品及其制备方法,所述用于治疗痛风的保健品包括下述原料:小麦草提取物、菊粉、富硒酵母、枸杞提取物、木瓜蛋白酶、雪莲、薄荷叶、灵芝、葛根提取物、陈皮、山楂、狗肝菜、桑叶提取物;其制备方法为:将雪莲、薄荷叶、灵芝、陈皮、山楂和狗肝菜泡入水中,待浸泡完毕后,取出各原料并进行干燥;并分别进行粉碎成粉末并混合均匀,得混合粉末;将混合粉末倒入酒中进行密封浸泡,浸泡完成后,过滤掉药渣得药酒;浓缩药酒得药粉,将剩余的原料和药粉混合均匀即可。本发明的有益效果为:本发明所述保健品能增强人体内细胞物质的代谢,防止骨质疏松及骨骼的老化,不但对痛风有治疗的作用,还可以防止其复发。
Description
技术领域
本发明属于保健品领域,具体涉及一种用于治疗痛风的保健品及其制备方法。
背景技术
痛风是一种由于嘌呤生物合成代谢增加,尿酸产生过多或因尿酸排泄不良而致血中尿酸升高,尿酸盐结晶沉积在关节滑膜、滑囊、软骨及其他组织中引起的反复发作性炎性疾病。近年来,痛风在群体中的发病率有所提高,患有痛风的患者的关节不能活动,难以行走,疼痛难以忍受,另外痛风患者需要忌口,海鲜、蘑菇、啤酒、动物内脏及豆制品等含嘌呤高的食物根本不能食用。目前治疗痛风病的药物有秋水仙碱、别嘌醇等,但只适用于患者在疼痛发作时服用,而且服用后只能缓解疼痛症状,治标不治本,长期服用,严重损害肾脏器官。另外,服用这些药都强调忌口,药物的副作用大。因此克服这些缺点,研究出一种新的副作用小的治疗痛风的药物,是人们需要努力的方向。
中国专利CN 103301358 A公开了一种治疗痛风的中草药物,该药物的组成成分及按重量份剂量如下:半枫荷30-60、土茯苓40-100、生黄柏25-40、宝盖草15-30、接骨木25-35、穿破石10-25、制毛青15-30、制马钱子20-50、独一味30-60、桑枝100-150、土牛膝100-150、酸木瓜100-200、制黑故纸50-100、车前草100-500。但本药物仅能缓解尿酸接触疼痛,只能稳定病情,不能达到根治的效果。
发明内容
本发明的目的是提供一种疗效快、副作用小且能根治痛风的一种用于治疗痛风的保健品及其制备方法。
本发明的目的是通过以下技术方案来实现的:
一种用于治疗痛风的保健品,包括下述重量份的原料:小麦草提取物5-10份、菊粉3-5份、富硒酵母1-3份、枸杞提取物1-3份、木瓜蛋白酶10-15份、雪莲1-3份、薄荷叶5-10份、灵芝1-3份、葛根提取物5-8份、陈皮3-5份、山楂3-5份、狗肝菜1-3份、桑叶提取物1-3份。
进一步地,所述用于治疗痛风的保健品包括下述重量份的原料:小麦草提取物8份、菊粉4份、富硒酵母2份、枸杞提取物2份、木瓜蛋白酶12份、雪莲2份、薄荷叶8份、灵芝2份、葛根提取物7份、陈皮4份、山楂4份、狗肝菜2份、桑叶提取物2份。
所述用于治疗痛风的保健品的制备方法,包括以下步骤:
(1)将雪莲、薄荷叶、灵芝、陈皮、山楂和狗肝菜泡入水中,待浸泡完毕后,分别取出各原料并进行干燥;
(2)将干燥后的雪莲、薄荷叶、灵芝、陈皮、山楂和狗肝菜分别进行粉碎,再将粉碎后的原料混合在一起,得混合粉末;
(3)将混合粉末倒入酒中进行密封浸泡,浸泡完毕后,过滤掉药渣得药酒;
(4)浓缩药酒得药膏,并将药膏进行干燥得药粉,将小麦草提取物、菊粉、富硒酵母、枸杞提取物、木瓜蛋白酶、葛根提取物、桑叶提取物和药粉混合均匀得所述的治疗痛风的保健品。
进一步地,步骤(1)中进行浸泡时,浸泡的各原料的重量之和与水的重量比为1:5-10,所述浸泡的时间为10-20min,所述干燥为将浸泡的各原料晾晒至各原料中含有的水分为6%-8%。将各原料进行浸泡,有助于清除原料表面的污物,浸泡的时间保持10-20min,避免原料中的有效成分过多的溶于水中。
进一步地,步骤(2)中所述混合粉末的细度为40-50目。将各原料进行粉碎,便于原料中的有效成分溶于酒中,而混合粉末的细度为40-50目,这样的细度方便过滤。
进一步地,步骤(3)中将混合粉末在80-90℃的温度下进行杀菌20-30min后再泡入酒中。所用的酒为38-45°的高粱酒。
进一步地,步骤(3)中所述混合粉末的重量与酒的重量比为1:5-10,所述密封浸泡的时间为30-60天。在浸泡的过程中前15天,每隔3天摇晃一下浸泡液,使浸泡的更均匀,十五天以后每隔一个星期摇晃一下浸泡液。俗话说“酒乃百药之长”酒本身也有药的作用,而且酒可以把原料中脂溶性和水溶性的东西全部溶出,这样“酒借药势,药借酒力”,能在很大程度上提高原料中有效成分的功效。
进一步地,步骤(4)中,所述干燥的温度为40-50℃,所述干燥的时间为6-8h。
小麦草提取物是小麦的种子经过泥土的发酵长出的幼苗,被公认为一种神奇的天然保健品。小麦草提取物中含有丰富的叶绿素、维生素A、维生素C、维生素E及维生素B族和矿物质及抗氧化剂SOD、有益酵素。
菊粉是植物中储备性多糖,主要来源于植物,菊粉是除淀粉外植物的另一种能量储存的形式是十分理想的功能性食品配料、同时也是生产低聚果糖、多聚果糖、高果糖浆、结晶果糖等产品的良好原料。菊粉有控制血脂、降低血糖、促进矿物质吸收的作用,此外,菊粉还具有调节肠道微生物菌群、改善肠道健康、防止便秘的作用。
富硒酵母就是在培养酵母的过程中加入硒元素,酵母生长时吸收利用了硒,使硒与酵母体内的蛋白质和多糖有机结合转化为生物硒,从而消除了化学硒(如亚硒酸钠)对人体的毒副反应和肠胃刺激,使硒能够更高效、更安全地被人体吸收利用。富硒酵母也是迄今为止国内最高效、最安全、营养最均衡的补硒制剂。硒是人体所必需的微量元素,有很重要的生理功能,与人类的健康密切相关。硒能够预防和抑制肿瘤、抗衰老、维持心血管系统的正常功能,预防动脉硬化和冠心病的出现。
枸杞提取物其拉丁文学名为:Lycium barbarum L,棕黄色粉末,其主要成分为枸杞多糖,枸杞多糖是一种水溶性多糖,由阿拉伯糖、葡萄糖、醋多糖、半糖、木糖乳糖、甘露、鼠李糖组成,枸杞多糖中含有微量元素和氨基酸,具有增强免疫力、抗肿瘤、降血脂、抗血栓及抗衰老的功效。
木瓜蛋白酶是一种具有生物活性的蛋白质,木瓜蛋白酶能裂解肉类中的胶原蛋白和肌肉纤维,而使肉的结构松散,能将肌动球蛋白和胶原蛋白降解成为小分子的多肽甚至氨基酸,使肉类变得嫩滑,并简化蛋白质结构使人体食用后易于消化吸收。
雪莲一般指雪莲花,学名:Saussurea involucrata,主要指菊科风毛菊属的植物,含有挥发油、生物碱、黄酮类、酚类、糖类、鞣质等活性成分,具有除寒痰,壮阳补血,暖宫散瘀,治月经不调、通经活血、散寒除湿、止血消肿的功效。
薄荷叶是植物薄荷的叶子,味道清凉,主要含有薄荷油、薄荷醇、薄荷酮、异薄荷酮、迷迭香酸等成份。具有消炎、抗菌、消肿止痛的作用,此外,它还能增加食欲、增加胃粘膜的供血量,改进消化功能。
灵芝又称林中灵、琼珍(学名:Ganoderma Lucidum Karst)是多孔菌科真菌灵芝的子实体,性平、味甘,具有补气安神、止咳平喘的功效,常用来治疗眩晕不眠、心悸气短、神经衰弱、虚劳咳喘等症状,此外,灵芝也具有延年益寿的功效。
葛根提取物来源于豆科植物野葛的干燥根,含有多种黄酮类成分,主要活性成分为大豆素、葛根素、大豆甙等,具有扩张血管,改善血液循环;降低心肌耗氧量,抑制癌细胞;增加冠脉流量,调整血液微循环的功能。
陈皮为芸香科植物橘及其栽培变种的成熟果皮。陈皮性温、味辛,具有理气健脾、调中、燥湿、化痰的功效,常用来治疗脾胃气滞之脘腹胀满、消化不良、咳嗽痰多等症状。陈皮的苦味物质是以柠檬苷和苦味素为代表的“类柠檬苦素”,这种类柠檬苦素味平和,易溶解于水,有助于食物的消化;此外,陈皮含有挥发油、橙皮甙、维生素B、C等成分,它所含的挥发油对胃肠道有温和刺激作用,可促进消化液的分泌,排除肠管内积气,增加食欲。
山楂为蔷薇科,味酸、微温,山楂中含有丰富的营养物质,山楂酸、柠檬酸,钙、铁、磷等多种营养物质,山楂具有促进胃液分泌和增加胃内酶素的功能,此外山楂中含有的牡荆素化合物,具有抗肿瘤的作用,山楂中提取的汁液不仅能阻断亚硝胺的合成,还可以抑制黄曲霉素的致癌作用。
狗肝菜一般指四籽马蓝,为双子叶植物药爵床科植物四籽马蓝的全草,具有清热解毒、凉血、生津、利尿的功效;常用来治疗实热内结之热毒斑疹、便血、小便不利、肿毒疔疮、跌打损伤、红肿出血等症状。
桑叶提取物以春蚕后期或霜降前桑树枝条上的第1~3位新叶加工的桑叶粉为原料,阴干,粉碎,分别用正丁醇、90%乙醇和水加温浸提,并喷雾干燥而得。桑叶提取物中含有桑叶黄酮、桑叶多酚、桑叶多糖等多种生理活性物质,对心脑血管病、高脂血症、糖尿病、肥胖症有一定的预防作用。
本发明的有益效果为:本本发明所述用于治疗痛风的保健品中的各原料有机地结合在一起,不仅能减轻痛风所带来的疼痛,而且能起到很好治疗痛风的效果,此外,本发明所述用于治疗痛风的保健品能增强人体内细胞物质的代谢,防止骨质疏松及骨骼的老化,不但对痛风有治疗的作用,还可以防止其复发。
本发明所述用于治疗痛风的保健品,经过酒进行浸泡,俗话说“酒乃百药之长”,酒本身也有药的作用,而且酒可以把原料中脂溶性和水溶性的东西全部溶出,这样“酒借药势,药借酒力”,能在很大程度上提高原料中有效成分的功效。
具体实施方式
实施例一
一种用于治疗痛风的保健品,包括下述重量份的原料:小麦草提取物5g、菊粉3g、富硒酵母1g、枸杞提取物1g、木瓜蛋白酶10g、雪莲1g、薄荷叶5g、灵芝1g、葛根提取物5g、陈皮3g、山楂3g、狗肝菜1g、桑叶提取物1g。
所述的用于治疗痛风的保健品的制备方法,包括以下步骤:
(1)将雪莲、薄荷叶、灵芝、陈皮、山楂和狗肝菜泡入水中,进行浸泡时,浸泡的各原料的重量之和与水的重量比为1:5,浸泡时间为10min,待浸泡完毕后,取出各原料将进行浸泡的各原料晾晒至各原料中含有的水份为6%;在水中浸泡的目的是清除原料表面的污物;
(2)将步骤(1)中干燥后的各原料分别进行粉碎,再将粉碎后的各原料混合在一起,得混合粉末,所述混合粉末的细度为40目;40目的混合粉末便于原料中的有效成分溶解在酒中且容易过滤;
(3)将混合粉末在80℃的温度下,杀菌20min后再将混合粉末泡入酒中,所述混合粉末与酒的重量比为1:5,密封保存30天,然后过滤掉药渣得药酒;在浸泡的过程中前15天,每隔3天摇晃一下浸泡液,使混合粉末浸泡的更均匀,十五天以后每隔一个星期摇晃一下浸泡液。俗话说“酒乃百药之长”酒本身也有药的作用,而且酒可以把原料中脂溶性和水溶性的东西全部溶出,这样“酒借药势,药借酒力”,能在很大程度上提高原料中有效成分的功效;
(4)浓缩药酒得药膏,将药膏在40℃的条件下,干燥6h得药粉,将小麦草提取物、菊粉、富硒酵母、枸杞提取物、木瓜蛋白酶、葛根提取物、桑叶提取物和药粉混合均匀得所述的治疗痛风的保健品。
实施例二
一种用于治疗痛风的保健品,包括下述重量份的原料:小麦草提取物8g、菊粉4g、富硒酵母2g、枸杞提取物2g、木瓜蛋白酶12g、雪莲2g、薄荷叶8g、灵芝2g、葛根提取物7g、陈皮4g、山楂4g、狗肝菜2g、桑叶提取物2g。
所述的用于治疗痛风的保健品的制备方法,包括以下步骤:
(1)将雪莲、薄荷叶、灵芝、陈皮、山楂和狗肝菜泡入水中,进行浸泡时,浸泡的各原料的重量之和与水的重量比为1:7,浸泡时间为15min,待浸泡完毕后,取出各原料将进行浸泡的各原料晾晒至各原料中含有的水份为7%;在水中浸泡的目的是清除原料表面的污物;
(2)将步骤(1)中干燥后的各原料分别进行粉碎,再将粉碎后的各原料混合在一起,得混合粉末,所述混合粉末的细度为45目;45目的混合粉末便于原料中的有效成分溶解在酒中且容易过滤;
(3)将混合粉末在85℃的温度下,杀菌25min后再将混合粉末泡入度数为38°的高粱酒中,所述混合粉末与酒的重量比为1:7,密封保存50天,然后过滤掉药渣得药酒;在浸泡的过程中前15天,每隔3天摇晃一下浸泡液,使混合粉末浸泡的更均匀,十五天以后每隔一个星期摇晃一下浸泡液。俗话说“酒乃百药之长”酒本身也有药的作用,而且酒可以把原料中脂溶性和水溶性的东西全部溶出,这样“酒借药势,药借酒力”,能在很大程度上提高原料中有效成分的功效;
(4)浓缩药酒得药膏,将药膏在45℃的条件下,干燥7h得得药粉,将小麦草提取物、菊粉、富硒酵母、枸杞提取物、木瓜蛋白酶、葛根提取物、桑叶提取物和药粉混合均匀得所述的治疗痛风的保健品。
实施例三
一种用于治疗痛风的保健品,包括下述重量份的原料:小麦草提取物10g、菊粉5g、富硒酵母3g、枸杞提取物3g、木瓜蛋白酶15g、雪莲3g、薄荷叶10g、灵芝3g、葛根提取物8g、陈皮5g、山楂5g、狗肝菜3g、桑叶提取物3g。
所述的用于治疗痛风的保健品的制备方法,包括以下步骤:
(1)将雪莲、薄荷叶、灵芝、陈皮、山楂和狗肝菜泡入水中,进行浸泡时,浸泡的各原料的重量之和与水的重量比均为1:10,浸泡时间为20min,待浸泡完毕后,取出各原料将进行浸泡的各原料晾晒至各原料中含有的水份为8%;在水中浸泡的目的是清除原料表面的污物;
(2)将步骤(1)中干燥后的各原料分别进行粉碎,再将粉碎后的各原料混合在一起,得混合粉末,所述混合粉末的细度为50目;50目的混合粉末便于原料中的有效成分溶解在酒中且容易过滤;
(3)将混合粉末在90℃的温度下,杀菌30min后再将混合粉末泡入度数为45°的高粱酒中,所述混合粉末与酒的重量比为1:10,密封保存60天,然后过滤掉药渣得药酒;在浸泡的过程中前15天,每隔3天摇晃一下浸泡液,使混合粉末浸泡的更均匀,十五天以后每隔一个星期摇晃一下浸泡液。俗话说“酒乃百药之长”酒本身也有药的作用,而且酒可以把原料中脂溶性和水溶性的东西全部溶出,这样“酒借药势,药借酒力”,能在很大程度上提高原料中有效成分的功效;
(4)浓缩药酒得药膏,将药膏在50℃的条件下,干燥8h得药粉,将小麦草提取物、菊粉、富硒酵母、枸杞提取物、木瓜蛋白酶、葛根提取物、桑叶提取物和药粉混合均匀得所述的治疗痛风的保健品。
实施例2所述用于治疗痛风的保健品的具体实施案例:
选取100例痛风患者,其中男性100位、女性100位,年龄30-70岁,服用本发明所述用于治疗痛风的保健品,服用方法为:早、中、晚分别服用本发明所述用于治疗痛风的保健品2g。服用本发明用于治疗痛风的保健品一个月后的实验效果为:有效:98%,无效2%。
有效:关节处疼痛和肿胀消失;
无效:关节处疼痛和肿胀无明显变化。
实施例2的具体实施案例
王某,女,30岁,2006年患痛风病,疼痛难忍,手脚关节已发生变形活动不便,经常性全身手脚关节红肿疼痛,严重时痛不欲生,用过很多药物进行治疗,但对疼痛只有缓解的作用,病情反复发作,且副作用比较大,2010年,开始服用本发明所述的用于治疗痛风的保健品,一个月后,王某的疼痛有所减轻,继续服用本发明所述用于治疗痛风的保健品两个月后,疼痛消失,关节红肿消失,坚持服用本发明所述用于治疗痛风的保健品半年后,王某痛风的症状消失,且至今无复发。
夏某,女,40岁,2008年患痛风病,右足及小腿疼痛,趾关节肿大,曾在多家医院治疗过,均为痊愈,服用本发明所述用于治疗痛风的保健品一个疗程后,疼痛感减轻,继续服用本发明所述用于治疗痛风的保健品两个疗程后,患者疼痛和肿胀基本消失,检查血尿酸接近正常,又坚持服用本发明所述用于治疗痛风的保健品一个疗程后,夏某恢复正常且至今未复发。
黄某,男,45岁,由于应酬比较多经常大量饮酒,2010年患者感觉脚趾、脚踝反复性肿痛,喝酒后往往肿痛加剧,局部红肿,经诊断为痛风,服用本发明所述用于治疗痛风的保健品一个月后,其疼痛感减轻,继续服用本发明所述用于治疗痛风的保健品两个月后,黄某痛风的症状消失,且至今未复发。
张某,男,48岁,货车司机,2010你患痛风病,右足及小腿疼痛,发作时火烧一样的疼痛,张某也看过很多医院,但是病情反复发作,经朋友介绍服用本发明所述用于治疗痛风的保健品。服用本发明所述用于治疗痛风的保健品一个月后,张某痛风发作时的疼痛感有所减轻,继续服用本发明所述用于治疗痛风的保健品两个月后,张某的痛风症状基本痊愈,又坚持服用本发明所述用于治疗痛风的保健品两个月,张某的痛风至今未复发。
郭某,男,68岁,体胖,喜欢吃海鲜,2012年确诊为痛风,右足及小腿疼痛,一直服用秋水仙碱药物进行治疗,但是病情反复发作且副作用比较明显,2015年经人介绍服用本发明所述用于治疗痛风的保健品,服用本发明所述用于治疗痛风的保健品一个月后,郭某的痛风发作时的疼痛感减轻,继续服用本发明所述用于治疗痛风的保健品两个月后,郭某痛风发作时的疼痛感基本消失,红肿也消失。
本发明不局限于上述最佳实施方式,任何人在本发明的启示下都可得出其他各种形式的产品,但不论在其细节上作任何变化,凡是具有与本申请相同或相近似的技术方案,均落在本发明的保护范围之内。
Claims (8)
1.一种用于治疗痛风的保健品,其特征在于,包括下述重量份的原料:小麦草提取物5-10份、菊粉3-5份、富硒酵母1-3份、枸杞提取物1-3份、木瓜蛋白酶10-15份、雪莲1-3份、薄荷叶5-10份、灵芝1-3份、葛根提取物5-8份、陈皮3-5份、山楂3-5份、狗肝菜1-3份、桑叶提取物1-3份。
2.根据权利要求1所述用于治疗痛风的保健品,其特征在于,包括下述重量份的原料:小麦草提取物8份、菊粉4份、富硒酵母2份、枸杞提取物2份、木瓜蛋白酶12份、雪莲2份、薄荷叶8份、灵芝2份、葛根提取物7份、陈皮4份、山楂4份、狗肝菜2份、桑叶提取物2份。
3.权利要求1-2之一所述用于治疗痛风的保健品的制备方法,其特征在于,包括以下步骤:
(1)将雪莲、薄荷叶、灵芝、陈皮、山楂和狗肝菜泡入水中,待浸泡完毕后,取出各原料并进行干燥;
(2)将干燥后的雪莲、薄荷叶、灵芝、陈皮、山楂和狗肝菜分别进行粉碎,再将粉碎后的原料混合在一起,得混合粉末;
(3)将混合粉末倒入酒中进行密封浸泡,浸泡完成后,过滤掉药渣得药酒;
(4)浓缩药酒得药膏,并将药膏进行干燥得药粉,将小麦草提取物、菊粉、富硒酵母、枸杞提取物、木瓜蛋白酶、葛根提取物、桑叶提取物和药粉混合均匀得所述的治疗痛风的保健品。
4.根据权利要求3所述用于治疗痛风的保健品的制备方法,其特征在于,步骤(1)中,进行所述浸泡时,浸泡的各原料的重量之和与水的重量比为1:5-10,所述浸泡的时间为10-20min,所述干燥为将浸泡的各原料晾晒至各原料中含有的水份为6%-8%。
5.根据权利要求3所述用于治疗痛风的保健品的制备方法,其特征在于,步骤(2)中所述混合粉末的细度为40-50目。
6.根据权利要求3所述用于治疗痛风的保健品的制备方法,其特征在于,步骤(3)中将混合粉末在80-90℃的温度下进行杀菌20-30min后再泡入酒中。
7.根据权利要求3所述用于治疗痛风的保健品的制备方法,其特征在于,步骤(3)中所述混合粉末与酒的重量比为1:5-10,所述密封浸泡的时间为30-60天。
8.根据权利要求3所述用于治疗痛风的保健品的制备方法,其特征在于,步骤(4)中,所述干燥的温度为40-50℃,所述干燥的时间为6-8h。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610498560.3A CN106072560A (zh) | 2016-06-29 | 2016-06-29 | 一种用于治疗痛风的保健品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610498560.3A CN106072560A (zh) | 2016-06-29 | 2016-06-29 | 一种用于治疗痛风的保健品及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106072560A true CN106072560A (zh) | 2016-11-09 |
Family
ID=57214605
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610498560.3A Pending CN106072560A (zh) | 2016-06-29 | 2016-06-29 | 一种用于治疗痛风的保健品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106072560A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107496437A (zh) * | 2017-08-11 | 2017-12-22 | 中国科学院西北高原生物研究所 | 黑果枸杞在制备降尿酸产品中的用途 |
CN112262983A (zh) * | 2020-10-27 | 2021-01-26 | 深圳市淳睿科技发展有限公司 | 一种具有抗糖化尿酸痛风功效的蔬果组合物及其制备方法 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101156918A (zh) * | 2007-10-10 | 2008-04-09 | 李志民 | 一种治疗痛风的药物及制备方法 |
CN101791383A (zh) * | 2010-01-06 | 2010-08-04 | 崔晓廷 | 复方菊苣系列产品及调节血糖血脂血尿酸的作用 |
CN101925361A (zh) * | 2008-01-23 | 2010-12-22 | 株式会社钟化 | 植物来源的高尿酸血症的预防或改善剂 |
CN102028703A (zh) * | 2009-12-03 | 2011-04-27 | 张冰 | 菊粉的新用途 |
CN102526263A (zh) * | 2011-12-20 | 2012-07-04 | 瑞坝(北京)新能源科技有限公司 | 一种预防和治疗痛风病的植物保健品 |
CN103181595A (zh) * | 2013-04-03 | 2013-07-03 | 刘银松 | 一种可降低尿酸的红萝卜汁保健饮料 |
CN103405682A (zh) * | 2013-08-22 | 2013-11-27 | 刘效义 | 一种治疗痛风的中药及其制备方法 |
CN103405757A (zh) * | 2013-08-28 | 2013-11-27 | 刘基林 | 一种用于保健品的组合物、保健品及其使用方法 |
CN104366636A (zh) * | 2014-10-30 | 2015-02-25 | 袁丁 | 一种平卧菊三七复合制剂及制备方法及应用 |
CN105055558A (zh) * | 2014-02-08 | 2015-11-18 | 刘向荣 | 一种治疗痛风的中药组合物 |
CN105250817A (zh) * | 2015-11-11 | 2016-01-20 | 广东明荃生物科技有限公司 | 一种治疗痛风、关节肿痛、降尿酸的含草本植物的茶 |
-
2016
- 2016-06-29 CN CN201610498560.3A patent/CN106072560A/zh active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101156918A (zh) * | 2007-10-10 | 2008-04-09 | 李志民 | 一种治疗痛风的药物及制备方法 |
CN101925361A (zh) * | 2008-01-23 | 2010-12-22 | 株式会社钟化 | 植物来源的高尿酸血症的预防或改善剂 |
CN102028703A (zh) * | 2009-12-03 | 2011-04-27 | 张冰 | 菊粉的新用途 |
CN101791383A (zh) * | 2010-01-06 | 2010-08-04 | 崔晓廷 | 复方菊苣系列产品及调节血糖血脂血尿酸的作用 |
CN102526263A (zh) * | 2011-12-20 | 2012-07-04 | 瑞坝(北京)新能源科技有限公司 | 一种预防和治疗痛风病的植物保健品 |
CN103181595A (zh) * | 2013-04-03 | 2013-07-03 | 刘银松 | 一种可降低尿酸的红萝卜汁保健饮料 |
CN103405682A (zh) * | 2013-08-22 | 2013-11-27 | 刘效义 | 一种治疗痛风的中药及其制备方法 |
CN103405757A (zh) * | 2013-08-28 | 2013-11-27 | 刘基林 | 一种用于保健品的组合物、保健品及其使用方法 |
CN105055558A (zh) * | 2014-02-08 | 2015-11-18 | 刘向荣 | 一种治疗痛风的中药组合物 |
CN104366636A (zh) * | 2014-10-30 | 2015-02-25 | 袁丁 | 一种平卧菊三七复合制剂及制备方法及应用 |
CN105250817A (zh) * | 2015-11-11 | 2016-01-20 | 广东明荃生物科技有限公司 | 一种治疗痛风、关节肿痛、降尿酸的含草本植物的茶 |
Non-Patent Citations (5)
Title |
---|
《健康大讲堂》编委会: "《痛风怎么吃》", 30 September 2015, 哈尔滨:黑龙江科学技术出版社 * |
范玲: "《痛风吃什么宜忌速查》", 31 January 2014, 北京:中国轻工业出版社 * |
董广民: "《图解《本草纲目》对症蔬果全书》", 31 July 2015, 北京:中医古籍出版社 * |
陈俊旭 等: "《吃错了,当然会生病!》", 30 August 2007, 沈阳:辽宁科学技术出版社 * |
马金江 等: "《植物天堂:地球植物大盘点》", 30 June 2014, 合肥:安徽美术出版社 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107496437A (zh) * | 2017-08-11 | 2017-12-22 | 中国科学院西北高原生物研究所 | 黑果枸杞在制备降尿酸产品中的用途 |
CN107496437B (zh) * | 2017-08-11 | 2019-06-25 | 中国科学院西北高原生物研究所 | 黑果枸杞在制备降尿酸产品中的用途 |
CN112262983A (zh) * | 2020-10-27 | 2021-01-26 | 深圳市淳睿科技发展有限公司 | 一种具有抗糖化尿酸痛风功效的蔬果组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104856009A (zh) | 一种杜仲雄花保健品 | |
CN102198262A (zh) | 一种治疗小儿轮状病毒性肠炎的中药制剂及其制备方法 | |
CN104013845B (zh) | 一种降血糖中药制剂及制备方法 | |
CN109350718A (zh) | 祛湿中药组合物及其制备方法 | |
CN103355444B (zh) | 一种健脾补气保健茶膏及制备方法 | |
CN106072560A (zh) | 一种用于治疗痛风的保健品及其制备方法 | |
CN102349950B (zh) | 一种食品、保健品或药物组合物及其制备方法和用途 | |
CN104474472A (zh) | 具有降三高作用的苦丁茶含片及其生产方法 | |
CN106434251A (zh) | 一种加入保健药材的醋曲块 | |
CN105012769A (zh) | 治疗糖尿病的中药组合物及中药组合物的制备方法 | |
CN103690811A (zh) | 一种降血压、预防头昏眼花的中药口服液及其制备方法 | |
CN104082483A (zh) | 一种葛根决明子茶及其制备方法 | |
CN108419869A (zh) | 一种清热排毒下火的组合物、饮料及其制备方法 | |
CN114404517A (zh) | 一种用于痛风和降低尿酸的组合物及其用途与制备方法 | |
CN103301342A (zh) | 一种促进生发中药制剂的配方及制备方法 | |
CN103349107B (zh) | 补脾养心保健茶膏及制备方法 | |
CN106902305A (zh) | 一种脾胃保健组合物及其制备方法 | |
CN102178866A (zh) | 用于气郁、血瘀体质人袪湿活血、软坚散结的中药制剂及其制备方法和应用 | |
CN105617268A (zh) | 一种治疗鳞屑角化型脚气的药物 | |
CN105878837B (zh) | 治疗肾病的中药 | |
CN104587342A (zh) | 适合甲亢患者饮用的药酒及制备工艺 | |
CN104069399A (zh) | 消除消化不良型口臭的中药汤剂及制备方法 | |
CN104435482A (zh) | 一种防治呼吸系统感染的中药稠膏及制法 | |
CN105288166A (zh) | 一种用于甲状腺肿大的中药组合物及其制备方法 | |
CN105942049A (zh) | 一种药用蚯蚓饲料添加剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161109 |
|
RJ01 | Rejection of invention patent application after publication |